Anthropic Acquires One-Person Biotech Mithril to Enter Drug Discovery

Anthropic has announced the acquisition of Mithril Medicine, a biotech startup with a single employee, marking its official entry into drug discovery. Founder Cody Tranbarger, who long ran the anonymous biotech Twitter account "Professor Oak," revealed his true identity when the deal was announced.

Confirmed

• Mithril Medicine was founded by Tranbarger alone and has been officially acquired by Anthropic
• Tranbarger used Claude to organize contracts, logistics, and experimental collaboration with 11 external labs, handing over much of the company's operations to Claude
• In under 18 months, a potential therapy for a rare (pediatric) muscular dystrophy went from an idea to positive results in mouse experiments
• Tranbarger himself posted to confirm he was the author behind the "Professor Oak" account

Why it matters

• The case is seen as a landmark example of the "one-person company + AI" model: AI not only assisted R&D but also took on core operational functions such as cross-lab contracts and logistics
• For Anthropic, this is a signature move extending from a model company into vertical applications like drug discovery
• Some commentators (as relayed by @kimmonismus) read it as a signal of Anthropic positioning ahead of an IPO

2026-10-28 ~ 2026-10-28 · 6 related posts

• [source] Anthropic Acquires One-Person Biotech Mithril, Founder Reveals He's 'Professor Oak' — a_baaron · 2026-10-28
• [source] Anthropic Enters Drug Discovery via One-Person Biotech Mithril Medicine; Read as Pre-IPO Signal — kimmonismus · 2026-10-28
• Anthropic acquires one-person biotech Mithril Medicine, whose founder used Claude to reach mice results in 18 months — Singularitarian · 2026-10-28
• Anthropic Acquires One-Person Biotech Startup That Used Claude to Coordinate 11 Labs — Polymarket · 2026-10-28

2 near-duplicate retellings: oran_ge · oran_ge